Taken together, the figure highlights a key mechanistic principle underlying the therapeutic rationale for multi-agonist strategies: while GLP-1R monotherapy achieves meaningful metabolic and hepatic benefits exclusively through indirect, systemic pathways, the addition of GIPR and - most importantly - GCGR co-agonism introduces complementary and increasingly direct hepatic mechanisms, providing the pharmacological basis for the superior efficacy observed with dual and triple agonists in MASLD/MASH
Methods 24 , 504511 (2014)
This has been documented in human clinical trials, in which people taking ME-3 orally for several weeks exhibit a 26% increase in total antioxidant activity. In summary, Lactobacillus fermentum ME-3 has been shown to have the highest Total Antioxidant Activity (TAA) and the highest Total Antioxidant Status (TAS) of any probiotic tested to date. 3) Supports cardiovascular health: Lactobacillus fermentum ME-3 has been shown to lower triglycerides and increase levels of the good HDL-cholesterol
It works through: 1
found that there was an overlap between abnormalities in intestinal flora and mitochondrial dysfunction, and that the intestinal flora might influence health and disease by regulating mitochondrial function [69]
4 Month Injectable Kit Dosed at 200mg weekly INCLUDES SUPPLIES $ 200 ($50/ month) *To ensure consistent treatment and prevent gaps or monthly drop-off issues, we do not offer monthly prescriptions or subscription plans